Breast cancer incidence and overdiagnosis in Catalonia (Spain)

被引:36
作者
Martinez-Alonso, Montserrat [1 ,2 ]
Vilaprinyo, Ester [3 ]
Marcos-Gragera, Rafael [4 ,5 ]
Rue, Montserrat [1 ,2 ]
机构
[1] Biomed Res Inst Lleida IRBLLEIDA, Basic Med Sci Dept, Lleida 25198, Catalonia, Spain
[2] Univ Lleida, Basic Med Sci Dept, Lleida 25008, Catalonia, Spain
[3] Hosp Mar IMIM, Evaluat & Clin Epidemiol Dept, Barcelona 08003, Catalonia, Spain
[4] Girona Canc Registry, Epidemiol Unit, Girona 17005, Catalonia, Spain
[5] ICO Hosp Dr Josep Trueta, Girona 17007, Catalonia, Spain
关键词
SOJOURN TIME; SCREENING MAMMOGRAPHY; REPRODUCTIVE FACTORS; REPLACEMENT THERAPY; HORMONE-THERAPY; MORTALITY; SENSITIVITY; ESTROGEN; TRENDS; OVERDETECTION;
D O I
10.1186/bcr2620
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Early detection of breast cancer (BC) with mammography may cause overdiagnosis and overtreatment, detecting tumors which would remain undiagnosed during a lifetime. The aims of this study were: first, to model invasive BC incidence trends in Catalonia (Spain) taking into account reproductive and screening data; and second, to quantify the extent of BC overdiagnosis. Methods: We modeled the incidence of invasive BC using a Poisson regression model. Explanatory variables were: age at diagnosis and cohort characteristics (completed fertility rate, percentage of women that use mammography at age 50, and year of birth). This model also was used to estimate the background incidence in the absence of screening. We used a probabilistic model to estimate the expected BC incidence if women in the population used mammography as reported in health surveys. The difference between the observed and expected cumulative incidences provided an estimate of overdiagnosis. Results: Incidence of invasive BC increased, especially in cohorts born from 1940 to 1955. The biggest increase was observed in these cohorts between the ages of 50 to 65 years, where the final BC incidence rates more than doubled the initial ones. Dissemination of mammography was significantly associated with BC incidence and overdiagnosis. Our estimates of overdiagnosis ranged from 0.4% to 46.6%, for women born around 1935 and 1950, respectively. Conclusions: Our results support the existence of overdiagnosis in Catalonia attributed to mammography usage, and the limited malignant potential of some tumors may play an important role. Women should be better informed about this risk. Research should be oriented towards personalized screening and risk assessment tools.
引用
收藏
页数:11
相关论文
共 66 条
[1]   Assessing the impact of screening mammography: breast cancer incidence and mortality rates in Connecticut (1943-2002) [J].
Anderson, William F. ;
Jatoi, Ismail ;
Devesa, Susan S. .
BREAST CANCER RESEARCH AND TREATMENT, 2006, 99 (03) :333-340
[2]  
[Anonymous], CANC INC 5 CONT
[3]   Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up [J].
Barbaglia, Gabriela ;
Macia, Francesc ;
Comas, Merce ;
Sala, Maria ;
del Mar Vernet, Maria ;
Casamitjana, Montserrat ;
Castells, Xavier .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2009, 16 (05) :1061-1064
[4]  
Beral V, 1997, LANCET, V349, P1103, DOI 10.1016/S0140-6736(05)62328-8
[5]   Effect of screening and adjuvant therapy on mortality from breast cancer [J].
Berry, DA ;
Cronin, KA ;
Plevritis, SK ;
Fryback, DG ;
Clarke, L ;
Zelen, M ;
Mandelblatt, JS ;
Yakovlev, AY ;
Habbema, JDF ;
Feuer, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1784-1792
[6]   Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review [J].
Biesheuvel, Corne ;
Barratt, Alexandra ;
Howard, Kirsten ;
Houssami, Nehmat ;
Irwig, Les .
LANCET ONCOLOGY, 2007, 8 (12) :1129-1138
[7]   Breast cancer incidence and mortality trends in 16 European countries [J].
Botha, JL ;
Bray, F ;
Sankila, R ;
Parkin, DM .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (12) :1718-1729
[8]  
Cabre A, 1989, REPROD CATALAN GENER
[9]   Population-based mammography screening and breast cancer incidence in New South Wales, Australia [J].
Chiu, C ;
Morrell, S ;
Page, A ;
Rickard, M ;
Brassil, A ;
Taylor, R .
CANCER CAUSES & CONTROL, 2006, 17 (02) :153-160
[10]   Risk factors for breast cancer according to estrogen and progesterone receptor status [J].
Colditz, GA ;
Rosner, BA ;
Chen, WY ;
Holmes, MD ;
Hankinson, SE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (03) :218-228